Vertex has reached a key moment because the U.S. Food and Drug Administration (FDA) is reviewing its candidate, suzetrigine, ...
Arcturus Therapeutics (ARCT) is continuing to evaluate the use of LUNAR-CF [ARCT-032] for the treatment of patients with Cystic Fibrosis [CF]. Read our latest report on the stock here.
Hosted on MSN2d
Affidavit: 8-year-old's mother, stepfather would lock him in his room and refuse to allow him to eatOfficers spoke to a social worker who told police an eight-year-old had been brought in for a routine appointment for cystic ...
A new form of diagnostic imaging is changing how doctors see and treat lung conditions like cystic fibrosis. For as long as ...
Citi initiates coverage of Gilead Sciences and Vertex Pharmaceuticals at buy in the large U.S. biotech sector. Read more here.
As physicians we take an oath to do no harm, yet are trapped providing care in a system that leaves patients confined and at ...
Cystic fibrosis shortened Megan Tims Phillips' life but didn't make it smaller. As her mother hoped for more time, daughter ...
EXCLUSIVE: Championed by the Daily Express, it has hailed 'amazing progress' for the 11,300 living with the genetic condition ...
Columnist Kristin Neva sometimes get overwhelmed by her increasing caregiver responsibilities, but it helps her to know she's not alone.
DelveInsight’s 'Non-Cystic Fibrosis Bronchiectasis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline non-cystic fibrosis bronchiectasis therapies in various stages of ...
In this article, we take a look at five biotech companies developing potentially transformative medicines to treat cystic ...
BX211 Phase 2 for treatment of Diabetic Foot Osteomyelitis (DFO) patient enrollment completed and on track to report topline results in Q1 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback